Related Experiment Video

Updated: Aug 7, 2026

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

Update on strategies to improve thrombolysis for acute myocardial infarction

S A Spinler1, S M Inverso

  • 1Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, Pennsylvania, USA.

Pharmacotherapy
|June 13, 2001
PubMed

Insights

Newer therapies for acute myocardial infarction (AMI) aim to improve blood flow by combining thrombolytics with antiplatelet agents. These strategies show promise in overcoming limitations of current treatments, enhancing reperfusion and reducing reocclusion.

Area of Science:

  • Cardiology
  • Pharmacology
  • Vascular Biology

Background:

  • Acute myocardial infarction (AMI) requires rapid restoration of coronary blood flow.
  • Current thrombolytic therapy improves survival but has limitations including incomplete reperfusion, bleeding, and reocclusion.
  • Complex dosing regimens can lead to errors.

Purpose of the Study:

  • To evaluate newer therapeutic strategies for acute myocardial infarction.
  • To address limitations of current thrombolytic regimens.
  • To explore combination therapies for improved outcomes.

Main Methods:

  • Investigated combination therapy with platelet glycoprotein IIb-IIIa receptor inhibitors and thrombolytic agents.
  • Evaluated the addition of unfractionated heparin or low-molecular-weight heparin.
  • Assessed pre-percutaneous coronary intervention administration of thrombolytic-antiplatelet therapy.

Main Results:

  • Combination therapy demonstrated faster clot lysis and greater flow rates compared to monotherapy.
  • Emerging strategies aim to enhance reperfusion and minimize adverse events.
  • Clinical trials are ongoing to validate these advanced treatment protocols.

Conclusions:

  • Novel therapeutic approaches, particularly combination therapies, offer improved efficacy in managing acute myocardial infarction.
  • These strategies hold potential to overcome existing treatment challenges.
  • Further research is warranted to optimize and implement these advanced treatments.

More Related Videos

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide09:52

Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide

Published on: January 15, 2017

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...